Get Answers about Supplements

This conversation examines whether black cumin (Nigella sativa) helps lower blood pressure, citing two studies from Pillser's database. It discusses mixed evidence, including a 2024 RCT using 1000 mg/day with neutral results, and advises consulting a healthcare professional before use.

A user asks whether saffron effectively reduces anxiety. The assistant reviews two clinical trials: one showing significant benefit in Parkinson's patients (100 mg/day) and another finding no effect in healthy adults with subclinical depression. The evidence is mixed and inconclusive.

A user asks whether inhaling olive oil benefits brain function or memory. The assistant clarifies there is no evidence for inhalation, reviews olive oil's proven benefits from oral consumption (e.g., cardiovascular health), and warns about risks like lipid pneumonia.

This chat explores how extra virgin olive oil (EVOO) can lower oxidative stress, backed by research showing its beneficial effects. Key components like polyphenols, vitamin E, and oleic acid act as antioxidants. Practical tips for including EVOO in your diet are also provided.

This conversation explores whether Lactobacillus rhamnosus GG (LGG) effectively reduces inflammation. Based on two studies from Pillser's research database, evidence leans beneficial, showing LGG modulates cytokines like IL-10 and TNF-α. However, the small study count suggests the evidence base is still developing.

This conversation provides a comprehensive guide to selecting a quality vitamin B complex, covering essential B vitamins, bioactive forms like methylfolate and methylcobalamin, appropriate dosages, third-party testing, and who may benefit from supplementation.

The conversation explores whether Lactobacillus rhamnosus GG improves physical functioning and quality of life in children with ADHD. Based on Pillser's research database, there is low evidence for a small beneficial effect on health-related quality of life, with 2 of 3 studies showing benefit. No specific data on physical functioning was found. The evidence is limited but promising, particularly at longer follow-up periods.

The user asks whether Saccharomyces boulardii is effective for preventing diarrhea while taking antibiotics. The assistant summarizes research evidence, noting low-strength support from RCTs, a typical dose of 500 mg twice daily, mixed results, and safety considerations such as taking it apart from antibiotics and caution in immunocompromised individuals.

This chat explores evidence from Pillser's research database showing that Lactobacillus rhamnosus GG (LGG) is highly effective in preventing antibiotic-associated diarrhea, reducing risk by about 70% according to a 2018 meta-analysis. Key findings and practical tips for use are discussed.

The user asks whether Lactobacillus rhamnosus GG helps reduce certain gut bacteria linked to health issues. The assistant explains that while no direct study on bacterial reduction exists, evidence shows LGG reduces diarrhea duration, intestinal inflammation, and faecal calprotectin, indicating it modulates gut microbiota favorably via competitive exclusion, antimicrobial production, and barrier strengthening.

A user asks whether Clostridium butyricum can reduce inflammation by lowering interferon-gamma (IFN-γ) levels. The assistant confirms, citing a randomized controlled trial showing significant IFN-γ reduction in elderly with malnutrition, plus broader anti-inflammatory effects on IL-6, TNF-α, and IL-10.

A user asks whether taking Clostridium butyricum probiotic alongside antidepressants can reduce anxiety. The assistant reviews a 2018 randomized trial showing significant improvement in anxiety symptoms, explains the gut-brain axis mechanism via butyrate, and highlights limitations including small sample size and open-label design. Concludes with cautious optimism and recommendation to consult a healthcare provider.

A user asks if Lactobacillus rhamnosus GG (LGG) helps reduce crying time in infants. The assistant reviews evidence from one RCT showing no significant benefit, contrasting it with other probiotics like L. reuteri, and advises consulting a pediatrician.

This conversation evaluates the effectiveness of Clostridium butyricum for achieving remission in conditions like IBD. Based on Pillser's database, the probiotic shows promising benefits for reducing inflammation, improving gut microbiota, and enhancing treatment response, though evidence is limited to small studies.

This chat explores evidence from two studies showing that Lactobacillus rhamnosus GG supplements may reduce intestinal inflammation. Key details include dosage, mechanism of action, and a note that one study involved HIV-infected individuals, affecting generalizability.

The user asks whether Lactobacillus rhamnosus GG (LGG) reduces the chance of diarrhea while on antibiotics. The assistant confirms, citing two studies showing beneficial effects, including a meta-analysis reporting a 70% risk reduction. Recommendations on timing and effectiveness are provided.

The user asked if Lactobacillus rhamnosus GG improves social functioning in children with ADHD. The assistant reviewed 3 studies, finding preliminary evidence for improved health-related quality of life but no specific data on social functioning. Effects were small, evidence low, and results mixed, highlighting the need for more research.

A user asks whether Lactobacillus rhamnosus GG helps reduce inflammation, specifically C-reactive protein levels. The assistant explains that evidence shows no significant effect on hs-CRP, but the probiotic may reduce other inflammatory markers like intestinal inflammation (calprotectin).

This conversation explores the evidence for using licorice root to reduce chronic inflammation, detailing its anti-inflammatory mechanisms, potential dosages, and important safety concerns like hypertension and toxicity. It also suggests safer alternatives like DGL and other evidence-backed supplements.

The user asked if Lactobacillus rhamnosus GG helps reduce stool volume. The assistant cited a 2019 meta-analysis of 4,208 participants showing no significant effect on stool volume in children with acute gastroenteritis. The conclusion is that the evidence does not support using this probiotic for reducing stool volume.

This conversation explores the evidence on Lactobacillus rhamnosus GG's impact on inflammation markers, including general cytokines (TNF-α, IL-6, IL-10) and specific lipopolysaccharide (LPS) levels. Findings show promising benefits for systemic inflammation but neutral results for LPS reduction based on Pillser's research database.

This conversation explores whether Lactobacillus rhamnosus GG can improve quality of life in children with ADHD. While no direct evidence exists for ADHD, LGG shows benefits for other pediatric conditions like food allergies. The response highlights the lack of clinical trials and the potential of the gut-brain axis.

This conversation explores the evidence for Lactobacillus rhamnosus GG (LGG) reducing Enterobacteriaceae levels. It notes promising results in preterm infants and children with gastroenteritis, mechanisms like lactic acid production and competition, but variability based on population, dosage, and baseline microbiota, concluding the evidence is suggestive but not uniformly strong.

This chat examines whether Lactobacillus rhamnosus GG helps with dermatitis. Based on one RCT showing no significant improvement, the evidence is insufficient to support its use for this condition.

The user asks whether Lactobacillus rhamnosus GG effectively reduces IBS symptoms. The assistant analyzes evidence from Pillser's database, covering abdominal pain, bowel movement frequency, and inflammation. It concludes that while results are mixed for pain and regularity, LGG shows consistent anti-inflammatory benefits, offering moderate but not definitive support for IBS.

This chat provides a comprehensive overview of creatine, including its role in energy production, benefits for exercise performance and cognitive function, safety profile, and common dosing protocols. It also discusses relevance for women's health and cites key research.

This conversation evaluates the evidence on L. rhamnosus GG for preventing necrotizing enterocolitis (NEC) in preterm infants. It discusses efficacy, safety concerns like rare sepsis cases, and risk factors such as extreme low birth weight or immunosuppression, emphasizing case-by-case medical decisions.

This conversation explores whether Lactobacillus rhamnosus GG (LGG) can shorten diarrhea duration, citing two studies from Pillser's database. It covers evidence for acute infectious and antibiotic-associated diarrhea, a recommended dose range of 1–10 billion CFU per day, and practical usage notes.

This chat explores the evidence from Pillser's research database on whether Clostridium butyricum, a butyrate-producing probiotic, can improve nutritional status. It summarizes one study showing a beneficial effect and discusses how the probiotic may support gut health and nutrient absorption.

A user asks whether Lactobacillus salivarius LS-33 effectively reduces LDL cholesterol. The assistant reviews the available evidence, citing a single 2012 RCT in adolescents with obesity that found no significant LDL reduction. It emphasizes strain specificity and suggests other probiotics with stronger evidence.

The user asks about Lactobacillus rhamnosus R0011's effect on diarrhea duration. The assistant explains that Pillser lacks specific studies on this strain but notes general evidence for L. rhamnosus, while highlighting stronger evidence for strain GG.

The user asked about using Lactobacillus rhamnosus HA-114 for weight loss. The assistant explained that current evidence does not strongly support its use for body fat reduction, highlighting strain-specific effects and noting that this strain is studied more for gut-brain health. Alternative probiotic strains with stronger metabolic health data were suggested.

A user asks about using Lactobacillus rhamnosus to delay delivery after premature rupture of membranes. The assistant emphasizes this is a medical emergency requiring immediate care, notes insufficient evidence in the Pillser database for this use, and advises consulting a doctor.

In this conversation, the user asks about expected weight gain from Lactobacillus reuteri DSM 17938 and its general safety. The assistant explains that no robust evidence links this probiotic strain to weight gain, it is generally safe for most people, but cautions for immunocompromised individuals.

This chat explores whether Lactobacillus plantarum 299v effectively prevents C. diff infections in hospitalized patients. It reviews clinical evidence, identifies who benefits most (e.g., older adults on antibiotics), and discusses timing, strain specificity, and safety considerations.

This conversation examines whether Lactobacillus reuteri DSM 17938 can reduce hospital stays. While no direct evidence exists, the probiotic shows moderate to high evidence for reducing diarrhea duration and gastrointestinal symptoms, which might indirectly shorten hospitalization in conditions like pediatric gastroenteritis.

A user asks whether Lactobacillus reuteri probiotics prevent severe necrotizing enterocolitis (NEC) in premature babies. The response explains that general probiotics reduce NEC risk, but evidence for L. reuteri is limited compared to strains like L. rhamnosus GG or multi-strain products, emphasizing medical supervision.

This conversation examines whether Lactobacillus rhamnosus GG can lower triglycerides based on current evidence. Pillser's database shows no direct studies on this strain for lipid profiles, though the species has modest evidence for inflammation, oxidative stress, and immune function.

A user asks whether Saccharomyces boulardii can reduce flatulence. The assistant explains that direct evidence is lacking, though the probiotic may indirectly help by improving gut health, reducing diarrhea, and alleviating digestive symptoms. It also notes possible temporary gas from probiotics.

A user asks if a probiotic containing Lacticaseibacillus casei can help improve radial inclination during recovery from a broken wrist. The assistant reviews evidence for anti-inflammatory and pain-reducing effects, but notes no direct link to bone healing or the specific wrist anatomy measure, recommending calcium, vitamin D, and protein instead.

This conversation explores whether Lactobacillus rhamnosus GR-1 can enhance cervical smear quality over time. Based on a 2019 randomized trial, evidence shows that this probiotic, combined with L. reuteri RC-14, significantly reduced mildly abnormal and unsatisfactory smear rates at 6 months, likely by supporting a healthy vaginal microbiome.

This session explores how magnesium can help maintain stable blood pressure and support circulation. It covers mechanisms like vasodilation and endothelial function, and references clinical trials showing blood pressure reduction. The discussion highlights the importance of adequate magnesium intake for cardiometabolic health.

This conversation examines the evidence for Lactobacillus salivarius UCC118's effect on C-peptide levels, finding no significant impact. It also reviews other health outcomes, including improved insulin sensitivity, reduced inflammation, lower gestational diabetes risk, and benefits for glucose metabolism and gut health.

Review of four studies on Lactobacillus plantarum 299v for abdominal pain, mainly in IBS. Three studies show benefit, but the largest trial found no significant difference. Evidence is promising but not conclusive.

A user asks if Lactobacillus salivarius UCC118 lowers triglyceride levels. The assistant finds no evidence for triglycerides but details strong evidence for improved insulin sensitivity, reduced inflammation, and reduced gestational diabetes risk, based on Pillser's research database.

User asked about Lactobacillus salivarius UCC118 for lowering cholesterol. Assistant cited one RCT (n=149) in women with gestational diabetes showing significant attenuation of LDL and total cholesterol rise compared to placebo. Limited evidence suggests potential benefit, but more research needed in broader populations.

The user asked whether Lactobacillus salivarius UCC118 can aid weight loss. The response explains that no evidence in Pillser's database supports this use for this strain, which is primarily studied for antimicrobial and gut health benefits, not weight management.

This chat reviews the effectiveness of Lactobacillus plantarum 299v for irritable bowel syndrome (IBS). Based on two studies from Pillser's database, the evidence is mixed—one meta-analysis shows a small benefit, while a recent RCT found no significant difference from placebo. The conclusion is not strongly conclusive.

This conversation explores the evidence on whether taking iron during pregnancy lowers the risk of anemia at delivery. It details research findings on iron supplementation's impact on iron deficiency, hemoglobin, ferritin, and anemia outcomes, summarizing effect sizes and evidence levels.

A user asks about evidence for tomatoes improving sleep quality. The assistant explains that while tomatoes contain melatonin and potassium, research does not support them as a sleep aid. Alternatives with stronger evidence include lavender, ashwagandha, L-theanine, and tart cherry. The response provides a detailed breakdown of relevant compounds and suggests evidence-based options.